Table 2.
Design of experiment 1.
| Group | H3N2 Influenza Strains Used for: | |||
|---|---|---|---|---|
|
Infection
(Week 0) |
Primary Vaccination
(Week 7) |
Booster Vaccination
(Week 11) |
Challenge
(Week 17) |
|
| Naïve challenge control | PBS | PBS | PBS | MO15 |
| Infection-immune challenge control | NC95 | PBS | PBS | |
| Infection-immune vaccinated (Homologous prime-boost) | NC95 | G08 | G08 | |
| NC95 | PA10 | PA10 | ||
| Infection-immune vaccinated (Heterologous prime-boost) |
NC95 | G08 | PA10 | |
| NC95 | PA10 | G08 | ||
PBS; phosphate buffered saline, NC95; A/Nanchang/95, G08; A/swine/Gent/172/2008, PA10; A/swine/Pennsylvania/A01076777/2010, MO15; A/swine/A01840724/2015.